Parkinson Disease
Conditions
Brief summary
The study determines whether standard medical care (dopamine) affects learning and retention of an upper limb feeding task in people with Parkinson's disease (PD) and whether training on the feeding task generalises to performance on an untrained upper limb buttoning task. Half the participants will train on the feeding task after they have taken their first dose of dopamine for the day (i.e. on medication state), while the other half will train on the same feeding task before taking their first daily dose of dopamine (i.e. off medication state).
Detailed description
Parkinson disease (PD) is an age related neurodegenerative disorder with symptomatic declines in motor function due to a loss of dopaminergic neurons within the basal ganglia. Ironically, treatment with exogenous dopamine-replacement medication (e.g. levodopa) may have positive effects on existing motor skills such as handwriting or walking, but may have detrimental effects on the learning of motor skills necessary for effective rehabilitation. Although dopamine medications are routinely prescribed to replace lost dopamine in the sensorimotor areas of the striatum, they may actually be overdosing the associative striatum, a candidate neuroanatomical correlate for motor learning. To date, however, this 'overdose' hypothesis has not been widely tested, given that few studies of motor learning in PD have reported or controlled for whether individuals were tested on or off their dopamine replacement medication.
Interventions
BEHAVIORALUpper limb feeding training
Participants will spoon two raw kidney beans at a time from a center proximal start cup to three distal target cups positioned 16 cm away at 45°, 90° and 135° around the start cup as fast as possible using their non-dominant hand. Spooning two beans between the start cup and a target cup is considered one repetition; each trial will consist of 15 repetitions. Participants will perform 50 trials per day for 3 consecutive days.
Sponsors
University of Utah
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Idiopathic Parkinson's disease confirmed by neurologist * Hoehn and Yahr stages 1 to 3 * On a stable dose of antiparkinsonian medication for the past month and will continue on this regime for at least another subsequent month * Walks unaided
Exclusion criteria
* Not taking dopamine replacement therapy * With prior surgical management for PD (e.g. deep brain stimulation) * With medication-resistant freezing of gait * Significant cognitive impairment (Montreal Cognitive Assessment score \<18) * Unstable medical conditions * Other neurological conditions * Unable to follow instructions or safely complete the training tasks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Task performance (response time) at initial retention, adjusted for baseline (first trial of acquisition on Day 3) | Day 8 (i.e. 48 hours after the last block of training) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Immediate decrement (difference in response time between initial retention and the last trial of acquisition) in task performance, adjusted for baseline (first trial of acquisition) | Day 5, Day 8 (i.e. 48 hours after the last block of training) | — |
| Delayed decrement (difference in response time between delayed retention and the last trial of acquisition) in task performance, adjusted for baseline (first trial of acquisition) | Day 5, Day 15 (i.e. 9 hours after the last block of training) | — |
| Rate of improvement | Day 1 through Day 3 | Rate of improvement (c) modelled on the exponential decay function: y = a + be(exp\[-x/c\]), where a is the final trial time value that the exponential decay function approaches (ie, asymptote), b is the scale of the learning from the first trial time to the value a, x is the trial number, 1/c is the number of trials needed to obtain asymptote (ie, 1 - e-1). |
| Nine hole peg test score | Day 15 (i.e. 9 days after the last block of training) | Time taken to complete the Nine Hole Peg Test at delayed retention, adjusted for baseline (Nine Hole Peg Test score at baseline, i.e. 3 days prior to the first block of training) |
| Buttoning task score | Day 15 (i.e. 9 days after the last block of training) | Time taken to complete the Buttoning task at delayed retention, adjusted for baseline (Buttoning task score at baseline, i.e. 3 days prior to the first block of training) |
Countries
United States
Outcome results
None listed